ITI Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
ITI Pharma and Healthcare Fund is a Thematic fund and Mirae Asset Nifty 500 Healthcare ETF is an ETF fund. ITI Pharma and Healthcare Fund charges 0.89% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%. Their portfolios overlap 76.0%: they hold 31 of the same securities.
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, ITI Pharma and Healthcare or Mirae Asset Nifty 500 Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 0.89%.
- Mirae Asset Nifty 500 Healthcare ETF fell less in its worst fall since 11-02-2026: −9.6% against −9.9%.
- ITI Pharma and Healthcare is the larger fund: ₹266 Cr against ₹15 Cr.
- Their portfolios overlap 76.0%: 31 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | ITI Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Fund house | ITI Mutual Fund | Mirae Asset Mutual Fund |
| Category | Thematic | ETF |
| AUM | ₹266 Cr (30-09-2026) | ₹15 Cr (30-09-2026) |
| NAV | ₹19.46 (Direct) | ₹21.44 |
| Expense ratio (Direct) | 0.89% | Not available |
| Expense ratio (Regular) | 2.59% | Not available |
| Riskometer | Very High | Very High |
| Benchmark | NIFTY Healthcare TRI | Nifty500 Healthcare TRI |
| Launch date | 08-11-2021 | Not available |
| Minimum investment | ₹5,000 | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units |
| Lock in | None | None |
| Fund managers | Animesh Singh, Nilay Dalal | Ekta Gala, amp, Ritesh Patel |
| Exit load | Exit load of 0.50%, if redeemed within 3 months. | NIL |
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund (Direct) | 0.00% | −1.04% | +11.74% | +9.43% | +20.30% | -- | -- |
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Year-wise Returns
| Year | ITI Pharma and HealthcareITI Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETFMirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| 2026to date | +14.07% | -- |
| 2025 | −8.24% | -- |
| 2024 | +43.95% | -- |
| 2023 | +34.39% | -- |
| 2022 | −6.68% | -- |
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Rolling Returns
Every holding period of both funds, against Nifty Healthcare Index TRI, the benchmark of ITI Pharma and Healthcare Fund
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | ITI Pharma and Healthcare Fund (Direct) | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Return (CAGR) | +14.34% | +23.46% |
| Standard deviation | 13.44% | 14.16% |
| Sharpe ratio | 0.63 | 1.29 |
| Sortino ratio | 0.89 | 1.90 |
| Maximum drawdown | −17.7% (17-06-2022) | −9.6% (23-10-2026) |
| Beta | 0.84 | 1.00 |
| Alpha | +1.08% | −0.22% |
From daily NAVs, 11-11-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
ITI Pharma and Healthcare Fund (Direct)
Mirae Asset Nifty 500 Healthcare ETF
Nifty Healthcare Index TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund (Direct) | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −4.2% |
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| Nifty Healthcare Index TRI | −9.2% | 31-08-2026 | 23-10-2026 | Not yet | -- | −2.9% |
From daily values since 11-02-2026, the first day every fund has.
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: ITI Pharma and Healthcare Fund, September 2026; Mirae Asset Nifty 500 Healthcare ETF, September 2026
Holdings in common
- Overlap
- 76.0%
- Held by both
- 31
- Only in ITI Pharma and Healthcare
- 6
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 13
| Security | % of ITI Pharma and Healthcare | % of Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.96% | 10.13% |
| Divi's Laboratories Limited | 9.51% | 8.76% |
| Apollo Hospitals Enterprise Limited | 5.45% | 6.24% |
| Torrent Pharmaceuticals Limited | 4.78% | 5.24% |
| Dr. Reddy's Laboratories Limited | 4.78% | 5.58% |
| Max Healthcare Institute Limited | 4.49% | 5.13% |
| Cipla Limited | 4.19% | 5.62% |
| Laurus Labs Limited | 4.02% | 5.72% |
| Aurobindo Pharma Limited | 4.01% | 3.43% |
| Fortis Healthcare Limited | 2.77% | 2.98% |
| Alkem Laboratories Limited | 3.09% | 2.31% |
| Mankind Pharma Limited | 3.78% | 2.10% |
| Lupin Limited | 2.04% | 3.66% |
| IPCA Laboratories Limited | 1.94% | 1.98% |
| Sai Life Sciences Limited | 1.87% | 1.56% |
| Aster DM Quality Care Limited | 1.59% | 1.38% |
| Neuland Laboratories Limited | 3.07% | 1.36% |
| Glenmark Pharmaceuticals Limited | 1.13% | 2.61% |
| Abbott India Limited | 2.14% | 1.04% |
| Gland Pharma Limited | 1.03% | 1.71% |
| Piramal Pharma Limited | 1.27% | 0.95% |
| Global Health Limited | 2.85% | 0.90% |
| GlaxoSmithKline Pharmaceuticals Limited | 0.96% | 0.85% |
| Biocon Limited | 0.81% | 1.91% |
| Zydus Lifesciences Limited | 0.73% | 2.14% |
| Anthem Biosciences Limited | 1.25% | 0.69% |
| Cohance Lifesciences Limited | 3.14% | 0.54% |
| Syngene International Limited | 0.57% | 0.51% |
| Rainbow Childrens Medicare Limited | 1.00% | 0.49% |
| Poly Medicure Limited | 1.48% | 0.47% |
| Caplin Point Laboratories Limited | 0.68% | 0.40% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 76.0% means 76.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in ITI Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Shilpa Medicare Limited | 1.61% |
| Healthcare Global Enterprises Limited | 1.47% |
| Shaily Engineering Plastics Limited | 1.22% |
| Supriya Lifescience Limited | 1.00% |
| Linde India Limited | 0.92% |
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Krishna Institute of Medical Sciences Ltd. | 1.48% |
| Wockhardt Ltd. | 1.30% |
| Acutaas Chemicals Ltd. | 1.26% |
| Ajanta Pharma Ltd. | 1.22% |
| Dr. Lal Path labs Ltd. | 1.15% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | ITI Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Equity | 99.3% | 100.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 0.7% | 0.0% |
Market cap of stocks
| Market cap | ITI Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Large Cap | 35.9% | 36.0% |
| Mid Cap | 40.5% | 45.6% |
| Small Cap | 23.0% | 18.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | ITI Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.8% | 77.8% |
| Healthcare Services | 20.9% | 21.7% |
| Healthcare Equipment & Supplies | 1.5% | 0.5% |
| Consumer Durables | 1.2% | 0.0% |
| Chemicals & Petrochemicals | 0.9% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
ITI Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | ITI Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 0.89% | Not available |
| Base expense ratio (Direct) | 0.58% | 0.00% |
| Total expense ratio (Regular) | 2.59% | Not available |
| Base expense ratio (Regular) | 2.10% | 0.16% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare ITI Pharma and Healthcare with
ITI Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF: Frequently Asked Questions
What is the difference between ITI Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
ITI Pharma and Healthcare Fund is a Thematic fund, Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, run by ITI Mutual Fund and Mirae Asset Mutual Fund. Their portfolios overlap 76.0%. ITI Pharma and Healthcare Fund charges 0.89% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%.
Which has the lower expense ratio, ITI Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 0.89%. These are the total expense ratios reported to AMFI.
How much do ITI Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF overlap?
76.0%. They hold 31 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, APOLLOHOSP. From each fund's latest monthly portfolio.
Which is riskier, ITI Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
On SEBI's riskometer, ITI Pharma and Healthcare Fund is rated Very High and Mirae Asset Nifty 500 Healthcare ETF Very High. Over their common history, the standard deviation of daily returns was 13.44% and 14.16% a year.
Can I invest in both ITI Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Yes. 76.0% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages ITI Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
ITI Pharma and Healthcare Fund: Animesh Singh, Nilay Dalal. Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.